Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer
Platinum derivatives are commonly used for the treatment of patients with metastatic triple-negative breast cancer (TNBC). However, resistance often develops, leading to treatment failure. This expansion cohort (part C2) of the previously reported phase 1b trial (NCT02157792) is based on the recomme...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Research
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |